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Quantitative phospho-proteomics 
reveals the Plasmodium merozoite 
triggers pre-invasion host kinase 
modification of the red cell 
cytoskeleton
Elizabeth S. Zuccala1,2,*, Timothy J. Satchwell3,*, Fiona Angrisano1,2, Yan Hong Tan1,2, 
Marieangela C. Wilson3, Kate J. Heesom3 & Jake Baum4
The invasive blood-stage malaria parasite – the merozoite – induces rapid morphological changes to the 
target erythrocyte during entry. However, evidence for active molecular changes in the host cell that 
accompany merozoite invasion is lacking. Here, we use invasion inhibition assays, erythrocyte resealing 
and high-definition imaging to explore red cell responses during invasion. We show that although 
merozoite entry does  not involve erythrocyte actin reorganisation, it does require ATP to complete 
the process. Towards dissecting the ATP requirement, we present an in depth quantitative phospho-
proteomic analysis of the erythrocyte during each stage of invasion. Specifically, we demonstrate 
extensive increased phosphorylation of erythrocyte proteins on merozoite attachment, including 
modification of the cytoskeletal proteins beta-spectrin and PIEZO1. The association with merozoite 
contact but not active entry demonstrates that parasite-dependent phosphorylation is mediated by 
host-cell kinase activity. This provides the first evidence that the erythrocyte is stimulated to respond to 
early invasion events through molecular changes in its membrane architecture.
The blood stage malaria parasite, the merozoite, achieves a remarkable feat in terms of cell biology. In less than 
two minutes it manages to successfully invade a target erythrocyte, a cell that is not only non-phagocytic, but 
whose membrane architecture also represents one of the most strong, resilient and flexible cellular structures 
known1. The process of parasite invasion forms a core foundation of malaria disease, which despite major gains in 
the past decade is still responsible for several hundred million cases and as many as half a million or more deaths 
globally each year2. Given the centrality of the blood stage of infection to disease pathology, there has been inten-
sive interest in understanding the mechanisms by which merozoites attach to and invade red blood cells as a route 
to develop novel strategies that combat entry and, as such, block malaria disease3.
Erythrocyte invasion is a stepwise process that begins when a merozoite forms an initial low-affinity attach-
ment to a red blood cell via any point on its surface. Attachment is associated with erythrocyte membrane defor-
mation and is followed by reorientation, where the merozoite brings its apical tip into contact with the target host 
cell4. An electron dense interface then forms between the two cells, called the tight or moving junction, which 
co-ordinates parasite-erythrocyte interactions during entry5,6. As the parasite invades it stimulates formation of a 
new cellular compartment, the parasitophorous vacuole (PV), inside the erythrocyte within which development 
proceeds.
Most mechanistic studies of invasion have focused on investigating the contribution of parasite factors that are 
important for invasion, and in particular on the role of parasite adhesive proteins and the merozoite actomyosin 
motor, which is responsible for driving the parasite into the host cell (reviewed in3). Much of this work has been 
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guided, at least in part, by a prevailing dogma that the erythrocyte is a passive victim to an entirely parasite driven 
process of membrane remodelling and penetration. This model is based primarily on evidence obtained using a 
distant relative of the malaria parasites, the apicomplexan parasite Toxoplasma gondii7,8, and fails to adequately 
consider evidence that the erythrocyte membrane is itself capable of extraordinary reversible deformation. This 
evidence includes the ability of erythrocytes to undergo continued transit through the narrow microcapillaries 
and splenic sinusoids of the body9, and recent evidence that erythrocyte actin might be more dynamic than previ-
ously assumed10. Given such observations, the potential involvement of a host-mediated component for regulat-
ing membrane and cytoskeletal proteins during parasite invasion becomes increasingly attractive. Recent research 
has demonstrated host-cell actin filament reorganization and accumulation at the point of entry during T. gondii 
tachyzoite invasion of fibroblasts11–13 and during murine malaria parasite, Plasmodium berghei, sporozoite inva-
sion of hepatocytes13. Moreover, a growing body of genetic studies on the role of T. gondii and Plasmodium inva-
sion proteins (reviewed in14) is beginning to undermine the centrality of parasite factors that were once thought 
to be essential to invasion, further paving the way for consideration of the erythrocyte as an active participant 
during merozoite entry.
A critical limitation to prior studies on the host cell contribution to merozoite invasion has been historical 
difficulties in isolating merozoites at the moment of invasion, in particular those from the most virulent malaria 
parasite P. falciparum. Thus, most work to date has not been able to differentiate host factors involved in invasion 
from those affecting post-invasion growth and development15–17. Nonetheless, there are compelling data that 
point to a role for a dynamic host cell in invasion (reviewed in1). For instance, studies focussed on the require-
ment of erythrocyte ATP in invasion point to the need for active remodelling of the host erythrocyte to support 
entry. For example, resealed erythrocytes produced by dialysis are resistant to invasion and/or ring-stage growth 
up to ~20 hours post-entry18. Similarly, erythrocytes dialysed in the presence of the non-hydrolysable ATP ana-
logue AMP-PNP were found to be unable to support either invasion, downstream growth or a combination of the 
two15. Finally, in addition to experimental evidence, recent biophysical modelling of cell-cell interactions during 
entry suggests erythrocyte membrane wrapping could account for a sizeable portion of the energy requirements 
for invasion given a localized destabilization of the erythrocyte membrane and with only a relatively small contri-
bution absolutely required from the merozoite itself19.
Indeed, the red blood cell possesses several complex pathways for altering the mechanical and biophysical 
characteristics of its membrane and underlying cytoskeleton, of which protein phosphorylation forms a key com-
ponent. Among phosphorylation events, several are known to lead to a decrease in membrane stability, such as 
phosphorylation of protein 4.1 and adducin by protein kinase C (PKC)20,21, dematin by PKA22, band 3 by Syk and 
Lyn kinases23 and casein kinase I and casein kinase II phosphorylation of beta-spectrin24,25. These changes lend 
support to the idea that parasite-mediated phosphorylation could underpin erythrocyte alterations required for 
merozoite entry. Analyses of post-invasion infections have identified an array of erythrocyte proteins that display 
increases in phosphorylation26–28 indicating that malaria parasites likely possess effectors required to remodel the 
erythrocyte though post-translational modification. Although postulated16, evidence that such a process occurs 
during invasion itself is lacking.
Here, we exploit the ability to achieve synchronised erythrocyte invasion using free and viable P. falciparum 
merozoites29 to visualize and quantitatively assess active erythrocyte processes in merozoite invasion. Through a 
combination of invasion assays and quantitative phospho-proteomics we demonstrate a clear host-erythrocyte 
kinase response to merozoite stimulus and report novel sites of modification associated with this contact.
Results
Merozoite invasion of the erythrocyte requires host cell ATP. To determine if P. falciparum mero-
zoite invasion requires host cell ATP, erythrocytes were pre-treated in ATP depletion medium containing 6 mM 
iodoacetamide, an inhibitor of glyceraldehyde-3-phosphate dehydrogenase, and 10 mM inosine, which together 
accelerate ATP consumption and block its production through glycolysis30. For instance, incubation of erythro-
cytes in depletion medium for 1 hour has been shown to irreversibly reduce ATP levels from physiological con-
centrations (approximately 1 mM–1.5 mM) down to 1–5 uM30. Here, erythrocytes depleted of ATP for increasing 
periods of time were subjected to invasion by free D10-PHG (a cytosolic GFP expressing parasite line31) mero-
zoites and invasion was quantified by flow cytometry as previously described32 (see schematic, Fig. 1a). Invasion 
into erythrocytes that had been treated in ATP depletion medium was severely impaired, with invasion reduced 
to ~40–65% of control levels for all depletion time points. However, increasing the time erythrocytes spent in 
depletion medium from 10 minutes up to 3 hours did not significantly increase invasion inhibition, indicating the 
action of the ATP depletion on erythrocyte ability to support invasion was likely rapid (Fig. 1b).
Iodoacetamide, whilst commonly used to inhibit glycolysis, is an alkylating reagent that modifies thiol groups 
in proteins by S-carboxyamidomethylation, and might thus have effects on erythrocytes beyond achieving irre-
versible ATP depletion. Notably, whereas incubation of erythrocytes for 3 hours in ATP depletion medium alters 
the biomechanical properties of their plasma membranes, incubation for 1 hour does not significantly reduce 
erythrocyte membrane fluctuation amplitudes33. To investigate the role of erythrocyte ATP in invasion in a more 
targeted manner, erythrocyte ATP levels were manipulated by resealing cells with the synthetic non-hydrolysable 
analogue AMP-PNP15. When performed at high haematocrit to reduce loss of cytoplasmic contents, resealed 
cells retain their ability to support P. falciparum invasion and growth, while also enabling the incorporation of 
fluorescent markers (Supplementary Fig. 1)34. Erythrocytes resealed either in the absence of ATP, with increasing 
amounts of ATP or with increasing concentrations of AMP-PNP, in the presence of fluorescent dextran to label 
resealed cells, were subjected to merozoite invasion and invasion rates into resealed cells were measured by flow 
cytometry (Fig. 1c,d). Compared to erythrocytes resealed in the presence of 1 mM ATP (the approximate normal 
physiological ATP concentration of erythrocytes), erythrocytes resealed with 10 mM AMP-PNP were inhibited 
from supporting merozoite invasion by ~60% (p < 0.0001, two-tailed unpaired t-test). Under all other conditions 
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Figure 1. Erythrocyte ATP is required for merozoite invasion. (a) Method for quantifying merozoite 
invasion by flow cytometry. Free GFP-expressing merozoites are added to fresh erythrocytes in a 96-well 
plate format under agitation for 40 min. Samples are stained with ethidium bromide (EtBr), which labels the 
parasite nucleus, washed and run on a flow cytometer using a high-throughput plate reader. After gating on 
erythrocytes, the proportion of red blood cells invaded by merozoites can be quantified. Erythrocytes alone 
are GFP and EtBr low, while red blood cells with associated parasites and free merozoites are GFP high. EtBr 
distinguishes between erythrocytes with bound extracellular merozoites, which stain high, and those infected 
with new rings, which stain low. Here, a new ring-stage parasitemia of 4.5% was achieved, a population that is 
absent when the invasion assay was performed in the presence of the invasion inhibitor heparin. (b) Invasion 
rate into cells depleted of ATP for different amounts of time, where invasion is expressed as a percentage 
relative to the new ring parasitemia of control cells that were incubated in PBS alone. **p < 0.05, ***p < 0.01, 
****p < 0.0001, NS = non-significant difference, two-tailed unpaired t-test. Graph displays mean + /− SEM. 
n = 3 in triplicate. (c) When free D10-PHG merozoites are added to resealed erythrocytes and stained with EtBr, 
dextran-Alexa647 allows quantitation of invasion into resealed cells by flow cytometry. (d) Invasion rate into 
erythrocytes resealed in the presence of different concentrations of either ATP or AMP-PNP, where invasion is 
expressed as a percentage relative to the new ring parasitemia of control cells that were resealed in the presence 
of 1 mM ATP. ****p < 0.0001, two-tailed unpaired t-test. Graph displays mean + /− SEM. n = 3 in triplicate. (e) 
Live imaging of erythrocytes resealed under different conditions, where dextran-Alexa647 marks successfully 
resealed cells.
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invasion rates were unaffected. Of note, all resealed erythrocyte populations contained a mixture of normal and 
mildly echinocytic erythrocytes, with the exception of erythrocytes resealed in the presence of 10 mM AMP-PNP, 
which all appeared reduced in size and severely echinocytic (Fig. 1e). Although these changes suggest that the 
relationship between the role of ATP during invasion and its critical role in modulating erythrocyte membrane 
and cytoskeletal integrity require further dissection, when these data are combined with results from depletion 
assays, the evidence is supportive of a requirement for erythrocyte ATP in parasite invasion.
Erythrocyte actin does not polymerize around invading merozoites. We next sought to define 
what active processes erythrocyte ATP might mediate during parasite entry. Given that host actin filaments accu-
mulation has been described for T. gondii tachyzoite and P. berghei sporozoite invasion13, we aimed to determine 
whether merozoite invasion resulted in similar levels of actin reorganization in the erythrocyte. Invasion assays 
with free P. falciparum merozoites were performed to capture different stages of invasion and samples analysed by 
widefield fluorescence microscopy, with RON4 labelling used to track the tight junction (Fig. 2a)35. Throughout 
all stages of invasion, RON4 labelling sat beneath host F-actin (labelled with phalloidin, a phallotoxin that does 
not bind Apicomplexan actin), and was distributed around the periphery of the cell. By contrast, phalloidin 
labelling was not apparent at or in front of the tight junction, indicating that actin did not enter the forming 
parasitophorous vacuole membrane (PVM). Finally, there was no apparent increase in phalloidin staining near 
the junction, which suggests that erythrocyte actin polymerization is not stimulated around the merozoite during 
invasion (Fig. 2b).
The labelling pattern of F-actin during invasion mirrored that of the transmembrane protein band 3 (Fig. 2c) 
and the cytoskeletal linker ankyrin (Fig. 2d), with no obvious reorganisation except for exclusion from the PVM 
at the tight junction. By contrast, the junctional complex member adducin had two distinct labelling patterns. 
It was seen either excluded from the nascent PVM or beyond the tight junction in a ring that surrounded the 
invading parasite (Fig. 2e). Although these observations for adducin are compatible with a model where the 
erythrocyte responds to invasion through remodelling the molecular architecture of its cytoskeleton, they do not 
support a situation where host cell actin reorganises around the entering merozoite.
Treatment of erythrocytes with anti-actin and myosin drugs does not inhibit invasion. It 
remains possible that only a small fraction of dynamic actin is required for invasion, beyond the resolution limits 
attained here. Therefore, to investigate whether host actin filament dynamics were functionally required for mero-
zoite entry, invasion drug inhibition assays were performed using cytochalasin D, a membrane permeable fungal 
metabolite that inhibits actin polymerisation36. In addition, to investigate a potential role for erythrocyte myosin 
during merozoite entry, 2,3-butanedione monoxime (BDM), a broad ATPase inhibitor37, and blebbistatin, a more 
specific inhibitor of non-muscle myosin II38, were used.
Prior to invasion, either erythrocytes or merozoites were treated with drug. Pre-treated erythrocytes were 
washed prior to invasion, however given assay limitations pre-treated merozoite samples retained drugs through-
out invasion. No invasion inhibition was observed in the erythrocyte pre-treated samples. Whereas merozoite 
pre-treatment with 200 nM cytochalasin D or 50 mM BDM strongly inhibited invasion (p < 0.0001, p < 0.0001, 
p = 0.0002 respectively, two-tailed unpaired t-test), no invasion inhibition was achieved when merozoites were 
pre-treated with blebbistatin (Fig. 3a). Given that drugs were present during invasion for merozoite pre-treatment 
samples, it is not wholly possible to distinguish merozoite and host specific drug effects. Moreover, the activities 
of these compounds are potentially reversible37,39,40. As such, although these data do not support a role for eryth-
rocyte actin dynamics or myosin activity in invasion, such roles cannot be completely discounted.
Therefore, to more specifically target erythrocyte actin, erythrocytes were resealed in the presence of increas-
ing concentrations of phalloidin and fluorescent dextran then subjected to merozoite invasion. Phalloidin only 
enters erythrocytes upon their permeabilization41 and binds with reasonable stability to filaments, preventing 
their depolymerisation42. Even at the highest concentration used (25 μ M) phalloidin had no effect on the ability of 
erythrocytes to support parasite entry (Fig. 3b). Although they do not categorically exclude a role for erythrocyte 
actin filament dynamics during merozoite invasion, these observations, combined with the washout experiments 
and imaging data, certainly suggest that host actin filament turnover is not involved in, or is relatively inconse-
quential to, merozoite entry.
Quantitative phospho-proteomics of the erythrocyte response to invasion. Having argued 
against a requirement for host cell ATP-dependent actin and myosin activity for malaria parasite entry, but 
observing some evidence for cytoskeletal remodelling (in particular adducin), we next sought to test whether 
early events in merozoite invasion might stimulate erythrocyte-mediated changes in host surface or cytoskeletal 
protein organisation. The centrality of phosphorylation in regulating erythrocyte membrane and cytoskeletal 
protein associations is well established43. As such, we explored the hypothesis that modulation of host cell phos-
phorylation of cytoskeletal and membrane proteins provides a means for merozoites to facilitate entry.
Preliminary investigations using total cell lysates of erythrocytes pre-loaded with radioactive phosphate (in 
the form of H332PO4) suggested that, relative to non-invaded controls, erythrocytes incubated with merozoites 
for 2 min exhibited a marked increase in general protein phosphorylation, with a particularly dramatic response 
seen for of high molecular weight proteins (Supplementary Fig. 2a-b). This approach, however, does not allow 
identification of the specific target protein or for the high-fidelity quantitation of phosphorylation changes. Thus, 
to explore this potential change in more detail, we adopted a phospho-proteomic approach to identify host pro-
teins and sites of modification associated with invasion. In addition, we used tandem mass tag (TMT)44 labelling 
of digested peptides in combination with phospho-peptide enrichment, thus enabling quantitative comparison of 
phospho-peptide abundance of six samples simultaneously assayed by mass spectrometry.
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Figure 2. Imaging of the erythrocyte cytoskeleton throughout merozoite invasion. Widefield deconvolution 
fluorescence imaging of fixed merozoite invasion samples labelled with anti-RON4, DAPI and markers of 
erythrocyte cytoskeletal proteins. (a) Schematic showing how RON4 labelling allows discernment of early, mid, 
late and complete invasion events. Early in invasion, during apical attachment, RON4 appears as a single point 
of fluorescence before expanding to form a ring around the invading merozoite as invasion progresses. When 
imaged in two dimensions, this ring appears as two single points of fluorescence on either side of the merozoite. 
The right junction marks the boundary between the erythrocyte plasma membrane and the parasitophorous 
vacuole membrane, and closes at the base of the parasite at the end of invasion. (b) Erythrocyte actin, labelled 
by phalloidin-Alexa594. (c,d) Band 3, ankyrin and adducin in invasion labelled with specific antibodies. PVM, 
parasitophorous vacuole membrane; RBC, red blood cell; TJ, tight junction.
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To isolate host cell phosphorylation changes during the early steps of invasion, red blood cells were subjected 
to rapid merozoite invasion assays (1.5 mins) under three different conditions, either in the presence of heparin, 
which inhibits firm merozoite attachment and reorientation45,46, the tight junction-blocking invasion inhibitory 
peptide R135 or without inhibition, with the aim of isolating phosphorylation events that occur at defined steps 
during merozoite entry. Each experiment was repeated four times each using different sets of donor erythrocytes, 
filtered merozoites and mass spectrometry runs. Use of the GFP expressing D10 PHG line in experiments three 
and four allowed quantitation of representative invasion rates achieved by flow cytometry (Supplementary Fig. 3).
Median Peptide fold-change values for high confidence peptides (FDR ≤ 1%) were produced by comparing the 
abundance of individual peptides in samples containing erythrocytes and merozoites (numerator) versus erythro-
cytes alone (denominator) for each of the three conditions tested. In order to directly test the effect of merozoites 
on erythrocytes, each control sample (denominator) was subjected to the same conditions, including the same 
drug treatment, as its corresponding invasion sample (numerator). Across the four experiments under all three 
conditions, most peptide median fold-change values were low and clustered together, while a small number of high 
fold-change and negative fold-change peptides were detected (Fig. 4a). The summary of all high-confidence eryth-
rocyte peptides detected along with their individual median fold-change values is presented in Supplementary 
Tables 1–3 and the identity of all high confidence P. falciparum peptides collected can be found in Supplementary 
Table 4. The full set of data collected for all experiments is presented in Supplementary Data 1.
The potentially transient nature of host protein phospho-modification allied to the small proportion of para-
sites undergoing active invasion within invasion assays provides significant challenges to the identification of sites 
of specific protein phosphorylation associated with merozoite attachment and/or invasion. The robust regression 
and outlier removal (ROUT) method was used to identify peptides with fold-change values that likely represented 
clear responses to merozoite presence, as opposed to those that likely represented natural variation or noise in 
the data. Outlier peptides with high median fold-change values, representing an increase in phosphorylation in 
response to merozoites, were detected in all experiments and across all conditions (Fig. 4b and Supplementary 
Fig. 4). A total of 26 unique outlier phospho-peptides were detected across the four experiments (Supplementary 
Tables 5–10), with the majority of outlier peptides detected across multiple conditions. Overall, outlier propor-
tions within each assay condition ranged from 3.5% to 9% of erythrocyte peptides (Supplementary Table 9).
The lack of outlier peptide segregation into the different invasion assay conditions is likely explained by 
experimental conditions. In order to achieve high invasion rates, invasion assays involved applying an excess 
of merozoites to erythrocytes compared to normal culture conditions29. Following our standard protocols, the 
concentration of merozoites typically produced is approximately 3− 4 × 105 merozoites/μ L (D. W. Wilson and 
M. A. Olshina, personal communication), yielding a merozoite to erythrocyte ratio in these invasion proteomics 
assays of between approximately 5:1 and 7:1. In contrast, the rate of erythrocytes invaded in these rapid 1.5 min 
assays ranged from around 2–4%, such that even in uninhibited invasion samples the vast majority of erythro-
cytes will have experienced merozoites transiently interacting or binding rather than active invasion events. As 
a result, phosphorylation events specific to invasion itself (downstream of erythrocyte interactions that occur 
Figure 3. Effect of actin and myosin inhibitors on merozoite invasion. (a) Merozoite invasion when either 
erythrocytes or merozoites were pre-treated with cytochalasin D (CD), blebbistatin (bleb) or BDM. Invasion 
percentage is expressed relative to the new ring parasitemia of control cells that were incubated in either 
PBS alone (for DMSO, heparin and myosin inhibitor treatment) or DMSO (for cytochalasin D treatment). 
****p < 0.0001, ***p < 0.01, two-tailed unpaired t-test. Graph displays mean + /− SEM. n = 3 in triplicate for all 
samples except BDM at 10 mM and 50 mM, which was performed three times in either duplicate or triplicate. 
(b) Invasion rate into erythrocytes resealed in the presence of different concentrations of phalloidin, where 
invasion is expressed as a percentage relative to the new ring parasitemia of control cells that were resealed in 
the absence of phalloidin. Graph displays mean + /− SEM, n = 3 in triplicate.
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under heparin treatment) are likely masked in a proteomic assay by the predominant host-parasite interaction 
occurring in the samples, that of transient and weak merozoite binding.
Additionally, whereas most outlier phospho-peptides were detected in multiple invasion conditions, just over 
half (54%) were detected in only one of the four proteomics repeats. This variability may be due to differences in 
merozoite numbers, variability between donor erythrocyte samples, efficiency of phospho-enrichment or chance 
differences in phospho-peptides detected by the mass spectrometer between experiments, with the abundance 
of both haemoglobin and merozoite peptides present within the sample likely limiting the depth of sequencing 
attained. Thus, to increase confidence in assignment of real changes, we took a conservative approach and limited 
analysis to outlier phospho-peptides that appeared in at least two of the four proteomics experiments (Table 1). 
Where multiple potential phosphorylated residues are located close to one another in the same peptide, relia-
ble determination of precisely which residues are phosphorylated can be problematic. Shortlisted peptides were 
interrogated for the accuracy of their phospho-site assignment using the SEQUEST delta Cn score and manual 
inspection of spectrometry ion fragmentation tables (Table 2). In all cases, except for beta-spectrin p-Y1302, the 
combination of scoring and manual inspection confirmed the identified phospho-sites. Although this result is 
strongly suggestive of correct phospho-site assignment, it remains possible that other sites within these peptides 
are the target of phosphorylation in response to merozoites. In particular, confident site assignments for protein 
4.1 phosphorylation at T378 and T740, considered as potentially ambiguous in initial analyses due to their close 
proximity, led to removal of protein 4.1 from the shortlist as these outlier events each occurred in only a single 
experiment. Given the inherent limitations in identifying phosphorylated resides by mass spectrometry, however, 
this does not necessarily preclude protein 4.1 from being a bone fide target of phosphorylation during invasion 
(Supplementary Fig. 6b).
Taking this approach, only peptides from beta-spectrin and PIEZO1 were outliers every time they were 
detected. The transformed log2 (fold-change) values for beta-spectrin peptides corresponding to p-S1301/Y1302 
across all three conditions ranged from 3.0 to 6.5 (median = 5.2, SEM = 0.42), indicating a large increase in abun-
dance in response to merozoites, whereas the two other detected phosphorylation sites in the protein (S36 and 
S2015) displayed minimal changes and were never detected as outliers (Fig. 5a). Although phosphorylation at 
S1301 has been previously reported in P. falciparum infected erythrocytes47, to our knowledge phosphorylation 
at Y1302 has not been identified before. Similarly, both PIEZO1 S1621 (median = 2.0, SEM = 0.14) and T1626 
(median = 2.6, SEM = 0.36) displayed consistently high log2 (fold- change) values (Fig. 5b), and phosphorylation 
at both sites has been previously identified (Supplementary Table 11).
The remaining shortlisted phospho-peptides from glycophorin C, eukaryotic translation initiation factor 
4B (EIF4B) and ankyrin, although outliers in at least two experiments, were also detected as non-outliers in 
Figure 4. Quantitative phospho-proteomics of merozoite invasion. (a) Median fold-change values for high 
confidence phosphorylated and non-phosphorylated erythrocyte peptides were determined by comparing 
individual peptide abundances between test (containing added merozoites) and control (erythrocytes alone) 
samples. Data were transformed by median centering for the three conditions containing either heparin-based 
invasion inhibition, R1 mediated inhibition or invading merozoites. Bars represent the global median and 
inter-quartile range for each sample set. (b) Histograms from one invasion assay subjected to quantitative 
phospho-proteomics, displaying the transformed log2 (median fold change) value for each phosphorylated and 
non-phosphorylated erythrocyte peptide detected. Outlier minimums, produced using the ROUT method, are 
marked with the dashed line. Histogram bin width is 0.2.
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other experiments (Supplementary Figs 5 and 6). In addition, a number of cytoskeletal and membrane pro-
teins contained phosphorylation events that had low fold changes compared to untreated erythrocytes and were 
consistently found not to be outliers. These included phospho-peptides from alpha-spectrin, band 3, myosin 9, 
alpha-adducin and solute carrier family 2 facilitated glucose transporter member 1 (SLC2A1) (Supplementary 
Figs 7 and 8). The presence of a broad range of protein phosphorylation events that did not increase in abundance 
in response to invasion provides confidence in the specificity of changes that were seen consistently across exper-
imental conditions.
Erythrocyte protein phosphorylation in response to merozoites is not due to mechanical stim-
ulation alone. Having demonstrated that erythrocytes respond to the presence of merozoites through phos-
phorylation, we wanted to exclude the possibility that this was simply due to mechanical stimulation by small 
particles. This question is particularly relevant given that these merozoite invasion assays are carried out in shaking 
Protein Peptide Mapped
Experiment 1 Experiment 2 Experiment 3 Experiment 4
Hep. R1 Inv. Hep. R1 Inv. Hep. R1 Inv. Hep. R1 Inv.
Beta-spectrin LLTSQDVsYDEAR S1301 Y Y Y Y Y Y ND ND Y ND ND ND
Beta-spectrin LLTSQDVSyDEAR Y1302 ND ND ND ND ND ND ND ND ND ND ND Y
PIEZO1 SGsEEAVTDPGER S1621 Y Y Y Y Y Y ND ND ND ND ND ND
PIEZO1 SGSEEAVtDPGER T1626 ND ND ND ND ND ND Y Y Y Y Y Y
Glycophorin C GTEFAEsADAALQGDPALQDAGDSSR S104 N N N ND ND ND Y Y Y Y Y Y
EIF4B SQSSDTEQQsPTSGGGK S504 N N N ND ND ND Y Y Y Y Y Y
EIF4B SQSSDtEQQSPTSGGGK T500 ND ND ND ND ND ND ND ND ND N N N
Protein 4.1 TQTVtISDNANAVK T738 ND ND ND ND ND ND ND ND Y ND ND ND
Protein 4.1 TQTVTIsDNANAVK S740 ND ND ND ND ND ND ND ND ND Y Y Y
Ankyrin RQDDATGAGQDsENEVSLVSGHQR/GDDATGAGQDsENEVSLVSGHQR S1666 N N N N N N Y N N Y Y Y
Ankyrin ITHsPtVSQVTER S1686, T1688 N Y Y N N N N N N ND ND ND
Ankyrin ITHSPtVsQVTER T1688, S1690 ND ND ND N N N ND ND ND Y N N
Glucose 1,6-bis-
phosphate synthase AVAGVmITAsHNR M171, S175 ND ND ND ND ND ND Y N N Y Y N
Table 1.  Shortlisted outlier phospho-peptides. 13 unique phospho‐peptides were detected as outliers in 
at least two experiments. Since confident assignment of phospho‐sites in mass spectrometry is often difficult 
when multiple possible phosphorylated residues are located in the same peptide, in cases where two identified 
phospho-sites were close to one another on the same peptide, such as for beta spectrin, the data for both 
peptides was considered collectively. Abbreviations: Y, yes peptide is an outlier; N, no peptide is not an outlier; 
ND, peptide not detected; Mapped, corresponding phospho‐site in the protein; Hep, invasion assay conducted 
in the presence of heparin; R1, assay used R1 peptide; Inv. uninhibited invasion assay. Modifications on S, T and 
Y residues are phosphorylation. Modification of M residues is oxidation.
Protein Peptide
Average SEQUEST delta Cn Score
Mod. Exp.1 Exp. 2 Exp. 3 Exp. 4
Beta Spectrin LLTSQDVsYDEAR S8 0.58 0.56 0.09** ND
Beta Spectrin LLTSQDVSyDEAR Y9 ND ND ND 0.00*
PIEZO1 SGsEEAVTDPGER S3 0.63 0.52 ND ND
PIEZO1 SGSEEAVtDPGER T8 ND ND 0.29 0.14
Glycophorin C GTEFAEsADAALQGDPALQDAGDSSR S7 0.32 ND 0.32 0.35
Protein 4.1 TQTVtISDNANAVK T5 ND ND 0.05** ND
Protein 4.1 TQTVTIsDNANAVK S7 ND ND ND 0.02**
EIF4B Protein SQSSDTEQQsPTSGGGK S10 0.10 ND 0.14 ND
EIF4B Protein SQSSDtEQQSPTSGGGK T6 ND ND ND 0.11
Ankyrin 1 RQDDATGAGQDsENEVSLVSGHQR/GDDATGAGQDsENEVSLVSGHQR S12/S11 0.56 0.58 0.35 0.32
Ankyrin 1 ITHsPtVSQVTER S4, T6 0.59 0.52 0.11 ND
Ankyrin 1 ITHSPtVsQVTER T6, S8 ND 0.15 ND 0.01**
Table 2.  Confidence measures of phospho-site assignment for shortlisted outlier phospho-peptides. For 
each experiment, the average SEQUEST delta Cn score was calculated for outlier phospho-peptides and those 
peptides with the same sequence and an alternative closely located phosphorylated residue, where a score of 
> 0.1 is considered a confident modified site assignment. *Manual inspection of peptide fragmentation ions 
indicated site assignment is ambiguous. **Manual inspection reveals good evidence for selected phospho-site. 
Abbreviations: Mod, modification site within peptide; Exp., experiment; ND, peptide not detected.
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conditions and noting that one of our top outlier phospho-peptides was from PIEZO1, a mechano-sensitive ion 
channel. To test whether mechanical force applied by merozoite-sized bodies could stimulate the phosphorylation 
events detected in invasion assays, we incubated erythrocytes under invasion-assay conditions with fluorescent 
microspheres of 1μ m diameter. Erythrocytes were incubated with shaking alone or in the presence of beads 
pre-coated with wheat germ agglutinin (WGA), or BlockAid, a commercially available blocking solution. This 
experiment was repeated twice and the two repeats were processed for quantitative phospho-proteomics and 
Figure 5. Phosphorylation of beta-spectrin and PIEZO1 in response to merozoites. Median centered 
individual phospho-peptide fold-change values pooled across the four invasion proteomic experiments for 
two proteins that contain a shortlisted outlier peptide, (a) beta-spectrin and (b) PIEZO1. Graphs display box 
and whisker plots showing the median, maximum and minimum values and inter-quartile range. Schematic 
representations of (c) beta-spectrin and (d) PIEZO1. Beta-spectrin phospho-sites identified through 
quantitative phospho-proteomics of invasion and their locations within the protein relative to key domains and 
regions of protein-protein interactions. Predicted membrane topology of PIEZO1based on Uniprot-derived 
consensus features from multiple prediction algorithms. Location of identified outlier phospho-sites is marked 
in red.
www.nature.com/scientificreports/
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analysed as for merozoite invasion samples. Compared to the range of median fold-change values obtained from 
our invasion assay proteomics (Fig. 4a), the distribution of values obtained in the two bead assays was more con-
densed and the maximum values much lower (Fig. 6a). When ROUT-based outlier identification was applied to 
these datasets (Fig. 6b), compared to the invasion assay experiments a lower proportion of outlier peptides were 
detected with fold-change values that were also low compared to the values obtained in the invasion proteom-
ics assays (Fig. 6b and Supplementary Tables 9 and 12). A full list of high confidence peptides can be found in 
Supplemental Data 2.
Shortlisted outlier peptides identified in invasion quantitative-proteomic assays were either absent among 
the phospho-peptides from the bead experiments, or present as non-outlier peptides (Supplementary Table 13), 
indicating that these phosphorylation events are likely stimulated specifically by merozoites. Notably, the same 
outlier beta-spectrin peptide was sequenced in assays both with and without BlockAid, however this peptide was 
not phosphorylated. For PIEZO1 the phospho-peptide corresponding to p-T1626 was detected as a non-outlier 
in both conditions. Combined, these data strongly suggest that early events in invasion by the blood stage malaria 
parasite stimulate ATP-dependent phosphorylation changes in the erythrocyte surface that might be required for 
successful entry into the human red blood cell.
Figure 6. Quantitative phospho-proteomics of erythrocyte response to microbeads. (a) Median fold-change 
values for high confidence phosphorylated and non-phosphorylated erythrocyte peptides were determined by 
comparing individual peptide abundances between test (containing added microbeads either pre-incubated 
with WGA or in the presence of BlockAid) and control (erythrocytes alone) samples. Values were transformed 
by median centering for the two conditions. Bars represent the global median and inter-quartile range for 
each sample set. (b) Histograms of each erythrocyte bead assay subjected to quantitative phospho-proteomics, 
displaying the transformed log2 (median fold change) values for each phosphorylated and non-phosphorylated 
erythrocyte peptide detected. Outlier boundaries, produced using the ROUT method, are marked with 
the dashed lines. Black dashed line represents upper boundary, where peptides with values above this line 
considered outliers, while the red dashed line marks the lower boundary, where peptides with values lower than 
this value identified as outliers. Histogram bin width is 0.05.
www.nature.com/scientificreports/
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Discussion
The proposition that merozoites hijack host pathways of membrane and cytoskeletal remodelling to invade 
requires, at its base, an erythrocyte capable of carrying out active processes. The possibility that red blood cell 
ATP is required for merozoite entry was first suggested over two decades ago, however to date no studies have 
been able to determine whether host ATP was a requirement of invasion itself or downstream growth up to 
~20 hours of intracellular development15,18,48. By exploiting the ability to directly and quantitatively assay P. falci-
parum invasion by flow cytometry, we demonstrate that a reduction in erythrocyte ATP indeed leads to a severe 
defect in merozoite invasion. Although the precise role of ATP in this context remains unclear, given the many 
morphological, biophysical and biochemical repercussions of ATP depletion, along with potential off-target 
effects of the treatments used to interfere with ATP, these results nonetheless support a model in which the red 
blood cell is co-opted to actively participate in its own infection by the merozoite.
Based on our combined imaging and invasion-inhibition analyses, which were unable to demonstrate either 
the presence of or a reliance on erythrocyte actin filament turnover during P. falciparum merozoite entry as 
observed in other apicomplexan modes of invasion13, we conclude that participation of host cell actin in mero-
zoite invasion appears unlikely. Although we cannot completely discount a subtle contribution of a subpopulation 
of actin filaments (suggested by recent erythrocyte imaging10), our data suggest little to no involvement of host 
actin turnover, and in particular stimulated polymerisation, during malaria parasite entry.
An alternative host-cell involvement during merozoite entry might be the localized destabilization of the 
erythrocyte cytoskeleton, which would likely increase the potential for membrane wrapping, thereby leading to 
a lower parasite energy requirement for invasion19. This is conceivable through disruption of vertical and lateral 
linkages of the cytoskeleton rather than through changes in actin filament length or organisation (reviewed in9). 
Intriguingly, the cytoskeletal linker adducin, but not ankyrin, which plays a similar role in the erythrocyte, was 
observed located beyond the tight junction with a labelling pattern suggestive of a PVM localization. Given that 
the known binding partners of adducin are either excluded from the PVM (band 3, spectrin, actin and potentially 
stomatin9), or have not been studied in this context (GLUT1), the mechanism of how adducin enters the PVM 
remains unclear. However, the potential that adducin, unbound to the underlying spectrin/actin cytoskeleton, is 
present during invasion and flows past the junction introduces the prospect that it may (and by extension, the 
junctional complex) be a target of cytoskeletal remodelling by the merozoite to achieve changes in host mem-
brane properties required to cause invagination of the erythrocyte plasma membrane and thus PV formation. 
Live imaging of cytoskeletal components during entry, though currently limited due to a paucity of markers for 
each protein, might reveal some of the changes that underlie these dynamic events.
Phosphorylation provides a key mechanism by which the erythrocyte is able to regulate the affinity of interac-
tions between membrane and cytoskeletal proteins in order to remodel its structure in response to stimuli. Here, 
we clearly demonstrate that a large number of red blood cell proteins are phosphorylated in the presence of mero-
zoites, with beta-spectrin and PIEZO1 consistently identified as targets of phosphorylation across biological and 
technical replicates. The fact that these increases in erythrocyte protein phosphorylation were detected not only 
in samples where parasites can enter host cells, but also in the presence of the invasion inhibitors R1 and heparin, 
suggests that erythrocytes respond to early interactions with merozoites. R1 treatment stalls invasion at reorien-
tation35, whereas heparin treatment allows weak, transient binding of merozoites to red blood cells and blocks 
apical reorientation and the events downstream45, likely through its interaction with processed forms of MSP1 on 
the merozoite surface. Moreover, merozoite binding in the presence of heparin allows only minimal deformations 
to the erythrocyte surface compared to those seen later in invasion46. Nonetheless, the phosphorylation events 
identified by quantitative proteomics appear to be merozoite specific, rather than based on the mechanical stim-
ulation of or sugar group-mediated binding to erythrocytes, raising the question of how the parasite is inducing 
these changes within the host-cell.
One possible mechanism is through secreted parasite factors, which might interact with the erythrocyte sur-
face prior to active invasion. Alternatively, receptor-ligand interactions between the two cells might explain the 
observed phosphorylation response. It is currently unclear as to whether key invasion ligands located on the sur-
face of merozoites bind erythrocytes in the presence of heparin, however heparin treatment does inhibit parasites 
that utilize different invasion pathways at comparable levels45, suggesting heparin may not act at the level of EBA 
and Rh binding. Ligation of complement receptor 1 (CR1) for instance, which is the receptor for PfRh449,50, stim-
ulates beta-spectrin phosphorylation and an increase in erythrocyte deformability in a CKII dependent manner24. 
In addition, binding of monoclonal F’ab fragments raised against glycophorin A, the receptor for EBA-17551, to 
the erythrocyte surface alters band 3 mobility in the membrane and increases erythrocyte rigidity52,53. These data 
indicate that ligand binding to erythrocyte invasion receptors has the ability to transmit signals into the host cell 
and alter its membrane and cytoskeletal properties. Whilst different strains of P. falciparum invade using different 
sets of initial receptor-ligand interactions (reviewed in54), it is likely that distinct pathways converge at some point 
to achieve a required alteration in erythrocyte membrane and cytoskeletal properties. Of note here, assays were 
carried out using a D10 parasite background, which lacks Rh2b and EBA-140 and invades in a chymotrypsin 
dependent manner55. Repetition of quantitative phospho-proteomics using parasite strains that rely on different 
sets of receptor ligand interactions might shed light on convergent and divergent parasite-initiated host cell sig-
nalling pathways.
Is an erythrocyte kinase recruited to prime the host cell for invasion? Since erythrocyte protein phosphoryl-
ation was detected prior to the point at which merozoites begin to secrete effectors into the target erythrocyte, it 
follows that a host cell kinase must be mediating these events. The kinases responsible for phosphorylating the 
outlier sites identifies through proteomics are unknown. Kinase prediction using NetPhosK is suggestive of a 
role for CKII and Ca2+/calmodulin-dependent protein kinase II (CAMKII) (Supplementary Table 14). Indeed, 
our data might provide molecular detail of relevance to the reported requirement for an erythrocyte protein with 
casein kinase activity in either merozoite invasion or early parasite intracellular development16. The use of kinase 
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inhibitors in tandem with invasion assays to investigate these hypotheses, whilst attractive, is complicated by 
the difficulty in attributing the effects of such inhibition as a result of human and Plasmodium kinase homology. 
CAMKII specific inhibitors do not appear to block P. falciparum invasion or early ring stage survival and although 
previous work has indicated that a CKII inhibitor (DRB) does not inhibit invasion, genetic approaches have indi-
cated that the P. falciparum CKII homologue is likely essential for blood stage survival and its activity has been 
implicated in merozoite invasion 56–60. There are currently no CKII inhibitors that could be used to confidently 
distinguish between host and parasite kinase activity during invasion, however, the divergence between the ort-
hologous might be sufficient to develop inhibitors that specifically target either human or P. falciparum CKII in 
the future 58,61.
It is possible that the observed phosphorylation events may represent responses to merozoite contact or 
secreted factors with little or no functional consequence, or serve as markers of other invasion-related events 
in the host cell. More attractively, phosphorylation may function to alter the properties of the cytoskeleton and 
potentially ‘prime’ the erythrocyte to be amenable to downstream invasion steps, however the consequences of 
each phosphorylation event identified in this study are currently unknown. Thus far, the only report of phospho-
rylation at beta-spectrin S1301 was in P. falciparum infected erythrocytes47. Located in spectrin repeat 10, this 
phosphorylation site is not located in any of the known beta-spectrin protein-protein interaction domains that 
form the key linkages within the cytoskeleton (Fig. 5c), making its potential effect on spectrin function difficult 
to predict. Finally, while the structure and membrane topology of human PIEZO1 have not been confirmed62, 
outlier phospho-sites located at S1621 and T1626 are both located with a predicted intracellular loop of this large 
multi-transmembrane domain protein (Fig. 5d). The exact function that this mechano-sensitive stretch-induced 
ion channel plays in normal erythrocyte function remains poorly understood, much less the potential effect of 
its post-translational modification in response to stimuli. Nevertheless, mutations and disruptions to PIEZO1 
have indicated a role in erythrocyte volume regulation, and in other cell types it has been shown to have a role 
in calcium ion transport (reviewed in63). In this light, the prospective involvement of PIEZO1, whether active or 
incidental, in response to merozoite stimulus is perhaps not surprising.
In summary, we present the first quantitative phospho-proteomic dataset addressing erythrocyte protein 
modification in response to stimulus by the early events of blood stage malaria parasite entry. We can exclude 
a significant contribution of host cell actin dynamics during the invasion process whilst demonstrating a host 
kinase response to the earliest membrane contact with the merozoite through the phosphorylation of prominent 
erythrocyte membrane and cytoskeletal proteins. It is now clear from this work that the erythrocyte is capable of 
and indeed does respond actively to attachment and invasion of the Plasmodium merozoite. With future develop-
ment of phospho-specific antibodies to each target protein and development of live imaging probes, we anticipate 
that this study will inform future efforts focused toward deciphering the potential for host cell signalling and 
kinase involvement in invasion and to understand the precise membrane and cytoskeletal protein remodelling 
events that underscore red blood cell responses to malaria parasite invasion.
Materials and Methods
Standard parasite tissue culture. P. falciparum strains D10 M3′ and D10-PHG32 were cultured in com-
plete culture medium, comprised of RPMI 1640 medium (GIBCO) supplemented with 25 mM HEPES, 0.0625% 
(v/v) gentamycin (Pfizer), 0.2% (v/v) NaHCO3 and either 0.4% (w/v) Albumax II (GIBCO) or a combination of 
0.2% (w/v) Albumax II and 5% (v/v) heat inactivated human serum from O+ donors (complete culture medium) 
(Australian Red Cross Blood Bank) (Walter and Eliza Hall Human Research Ethics Committee (ethics number 
86/17) and an Australian Red Cross Blood Service Agreement (11-09VIC-01)). Cultures were synchronised as 
previously described using a combination of sorbitol (Sigma) synchronization64 and treatment with 20 IU/mL 
(approximately 153 μ g/mL) medicinal grade heparin (porcine mucous, Pfizer, AUST R 49232)45.
Merozoite preparation and standard invasion assay. Unless otherwise specified, free merozoites 
were isolated and used in standard erythrocyte invasion assays according to published protocols29. Assays were 
incubated at 37 °C for specified times on rotation at either 1,100 rpm (imaging and phosphorylation assays) or 
400 rpm (invasion quantitation by flow cytometry).
Imaging of merozoite invasion. Imaging of invasion followed established methods35. For immunofluo-
rescence, primary antibodies used were mouse anti-RON4 1:500 and rabbit anti-RON4 1:25035, rabbit anti-alpha 
adducin 1:1000, rabbit anti -ankyrin 1:1000 (kind gifts from Vann Bennett, Duke University) and rat-anti band 3 
clone BRAC1865 (kind gift from David Anstee, NHSBT Bristol). Secondary antibodies used were goat anti-mouse 
Alexa Fluor® 488 (A-11001, ThermoFisher), goat anti-rabbit Alexa Fluor® 488 (A-11008), goat anti rabbit Alexa 
Fluor® 594 (A-11037) or goat anti-rat Alexa Fluor® 594 (A-11007). Phalloidin Alexa Fluor® 594 1:50 (A12381, 
ThermoFisher) was used to label erythrocyte F-actin. Samples were mounted in Vectashield (Vector Laboratories, 
H-1000) containing 0.1 ng/μ L 4′ ,6-diamidino- 2-phenylindole (DAPI, Life technologies, D3571) and widefield 
deconvolution imaging performed using a DeltaVision Elite equipped with a TrueLight illumination system, 
Photometrics CoolSnap HQ2 camera, 100 × 1.40 NA objective and SoftWoRx v6 software.
Production of assays for quantitation of invasion by flow cytometry. Where indicated, erythro-
cytes were pre-treated with the actin and myosin inhibitors cytochalasin D (C2618, Sigma), blebbistatin (B0560, 
Sigma) and 2,3-Butanedione monoxime (BDM, B0753, Sigma) prior to merozoite invasion for 1 h at 37 °C, and 
washed two times. Filtered merozoites were then added to treated erythrocytes and invasion assays completed as 
published32.
To deplete erythrocytes of ATP prior to invasion, erythrocytes were washed three times in PBS and incubated 
at 8% haematocrit in either PBS alone or depletion media containing 6 mM iodoacetamide (I6125, Sigma) and 
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10 mM inosine (I4125, Sigma) in PBS for between 10 min and 3 h at 37 °C in a humidifying oven on rotation. 
Treated cells were then washed three times in incomplete culture medium and used in merozoite invasion assays.
Invasion assays for proteomics. Quantitative proteomic experiments were performed using lysates 
of erythrocytes undergoing active merozoite invasion or in the presence of either 40 IU/mL heparin (Pfizer) 
or 100 μ g/mL R1 peptide (GL Biochem), where invasion was allowed to continue for 1.5 min to enrich for 
mid-invasion events. As such, invasion rates obtained tended to be lower than for standard flow cytometry based 
assays (above), which allow merozoite-erythrocyte interaction for 30–40 mins. For assays where D10-PHG par-
asites were used, a proportion of the sample was used for evaluation of invasion rate by flow cytometry. The 
remaining sample was then rapidly centrifuged (676 × g, 30 sec), supernatant containing media and unbound 
merozoites removed and pellets snap frozen on dry ice to stop invasion.
For control microbead assays, erythrocytes were isolated from O+ platelet apheresis blood waste (NHSBT, 
Bristol, UK) from healthy donors with informed consent for research use in accordance with the Declaration 
of Helsinki and approval from the Local Research Ethics Committee (REC 12/SW/0199). Fluospheres of 1 μ m 
diameter (Life Technologies, F8852) (0.67% solution) were incubated with BlockAid solution (Life Technologies, 
B10710) or wheat germ agglutinin (Sigma, L9640) at 50μ g/mL for 1 h with rotation at room temperature. Beads 
were washed once in complete culture media, resuspended in complete culture media at a concentration of 
3.6 × 106/μ L and sonicated for 1 min in a sonicating water bath. A concentration of 3.6 × 106/μ L microbeads was 
selected to mimic standard merozoite invasion assay conditions, which typically involve incubation of erythro-
cytes with filtered merozoites at between 3 × 106/μ L and 4 × 106/μ L (Danny Wilson and Maya Olshina, Walter 
and Eliza Hall Institute of Medical Research, personal communication). Assays were performed as described for 
merozoite invasion assays.
Erythrocyte resealing. O+ erythrocytes supplied in equal amounts from two different donors were washed 
three times in incomplete culture medium, and 100 μ L of packed erythrocytes (pRBCs) used per assay. To lyse, 
pRBCs were resuspended in 100 μ L of lysis buffer at 4 °C (5mM K2HPO4, 1 mM ATP, pH 7.4) and incubated on 
ice, with periodical agitation, for 10 min. To reseal, 20 μ L of resealing buffer (475 mM KoAc, 25 mM Na2HPO4, 
25 mM MgCl2, 237.5 mM KCl, 1 mM ATP, 5 mM GTP, 1.5 mM DTT, pH 7) was added to the lysing erythro-
cytes and each sample incubated at 37 °C on rotation for 1 h in a humidifying oven. Samples were washed three 
times in incomplete culture medium. For resealing of membrane impermeable compounds into erythrocytes, the 
desired compounds were included in the lysis buffer. To label resealed erythrocytes, dextran-Alexa Fluor® 647 
10,000 MW (D-22914, ThermoFisher) was included in lysis buffer resulting in a final concentration of 125 μ g/
mL. Phalloidin (P3457) was supplied by ThermoFisher. For ATP studies, various concentrations of either ATP 
(adenosine 5′ -triphosphate disodium salt, A6559, Sigma) or AMP-PNP (adenosine 5′ –(β ,γ -imido)triphosphate 
tetralithium salt hydrate, A2647, Sigma), were included in both the lysis and resealing buffers, with ATP or ana-
logue buffer concentrations ranging from 1 mM to 10 mM in equal amounts of solvent (DDW).
Quantitative phospho-proteomics. Sample Preparation. Samples were lysed for 10 min on ice in 
lysis buffer containing 20 mM Tris-HCl pH 8.0, 137 mM NaCl, 10 mM EDTA, 100 mM NaF, 1% (v/v) Nonidet 
P-40, 10 mM Na3VO4, 2 mM PMSF, 1% (v/v) protease inhibitor cocktail set V (Merck Millipore) and 1% (v/v) 
phosphatase inhibitor cocktail set IV (Merck Millipore). Total protein concentration of lysates was quantified 
using a DC Protein Assay (BioRad) and 100 μ g of each sample labelled using TMTsixplex reagents according 
to manufacturer’s instructions (Thermo Scientific). The labelled samples were pooled and then subjected to 
phospho-peptide enrichment using a TiO2-based enrichment kit, according to the manufacturer’s instructions 
(Pierce). The phospho-enriched sample was then analysed by RP nano-LC MSMS using an LTQ-Orbitrap Velos 
mass spectrometer.
Nano-LC Mass Spectromerty. Each phospho-enriched sample was fractionated using an Ultimate 3000 nano-
HPLC system in line with an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). In brief, peptides in 
1% (v/v) formic acid were injected onto an Acclaim PepMap C18 nano-trap column (Thermo Scientific). After 
washing with 0.5% (v/v) acetonitrile 0.1% (v/v) formic acid peptides were resolved on a 250 mm × 75 μ m Acclaim 
PepMap C18 reverse phase analytical column (Thermo Scientific) over a 150 min organic gradient, using seven 
gradient segments (1–6% solvent A over 1 min, 6–15% B over 58 min, 15–32% B over 58 min, 32–40% B over 
3 min, 40–90% B over 1 min, held at 90% B for 6 min and then reduced to 1% B over 1min) with a flow rate of 
300 nL/min. Solvent A was 0.1% (v/v) formic acid and Solvent B was aqueous 80% (v/v) acetonitrile in 0.1% 
(v/v) formic acid. Peptides were ionized by nano-electrospray ionization at 2.1 kV and a capillary temperature of 
250 °C.
Tandem mass spectra were acquired using an LTQ- Orbitrap Velos mass spectrometer controlled by Xcalibur 
2.1 software (Thermo Scientific) and operated in data-dependent acquisition mode. The Orbitrap was set to ana-
lyse the survey scans at 60,000 resolution (at m/z 400) in the mass range m/z 300 to 1800 and the top 10 multiply 
charged ions in each duty cycle selected for MS/MS fragmentation using higher-energy collisional dissociation 
(HCD) with a normalised collision energy of 45%, activation time of 0.1 ms and at a resolution of 7500 within 
the Orbitrap. Charge state filtering, where unassigned precursor ions were not selected for fragmentation, and 
dynamic exclusion (repeat count, 1; repeat duration, 30 s; exclusion list size, 500) was used.
Data Processing. The raw data files were processed using Proteome Discoverer software v1.2 (Thermo Scientific) 
and searched against a combined database consisting of the UniProt Human and P. falciparum 3D7 databases 
using the SEQUEST algorithm. Peptide precursor mass tolerance was set at 10 ppm, and MS/MS tolerance was set 
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at 20 mmu. Search criteria included carbamidomethylation of cysteine (+ 57.0214) and the addition of the TMT 
6Plex mass tag (+ 229.163) to peptide N-termini and lysine as fixed modifications and oxidation of methionine 
(+ 15.9949) and phosphorylation of serine, threonine and tyrosine (79.966Da) as variable modifications. Searches 
were performed with full tryptic digestion and a maximum of 1 missed cleavage was allowed. The reverse data-
base search option was enabled and all peptide data was filtered to satisfy false discovery rate (FDR) of 5%. The 
Proteome Discoverer software generates a reverse “decoy” database from the same protein database used for 
the search and any peptides passing the initial filtering parameters that were derived from this decoy database 
are defined as false positive identifications. The minimum cross-correlation factor (Xcorr) filter was readjusted 
for each individual charge state separately to optimally meet the predetermined target FDR of 5% based on the 
number of random false positive matches from the reverse decoy database. Thus each data set has its own passing 
parameters. Quantitation was done using a peak integration window tolerance of 0.0075 Da with the integration 
method set as the most confident centroid.
Data Analysis. Quantitative peptide fold-change data was manually curated using Excel v14.4.1 to select pep-
tides of human origin with a high confidence measure (FDR ≤ 1%). Peptides derived from known serum pro-
teins, based on localisation data from the Uniprot database, were excluded from further analysis. Where multiple 
spectra were obtained for the same peptide within an experiment, the median fold-change of the reads was taken. 
Peptide medians were then transformed to log base 2 and median centered to adjust for loading, a linear transfor-
mation commonly used in microarray analyses66, by subtracting the global median of the dataset from each indi-
vidual median peptide fold-change value. To identify outliers, representing fold-change values that fall outside the 
assumed normal variation in the data, the ROUT method was employed67 using Prism v6. This method assumes a 
dataset follows a normal distribution and uses non-linear regression to identify outliers with a false discovery rate 
of 1%67. ROUT analysis was applied to median fold-change values prior to logarithmic transformation.
The confidence of phospho-site localisations within individual outlier peptides was assessed using Scaffold 
v4 (Proteome Software) to calculate the SEQUEST delta Cn score, which is a measure of the difference in the top 
two peptide sequence correlation scores (Xcorr), where a score of > 0.1 is considered a confident modified site 
assignment68–70. Visualization of individual peptide spectra and their corresponding ion fragmentation tables 
was also performed using Scaffold v4 to manually confirm confidence measures provided by the delta Cn scores. 
Peptide modification sites were mapped within their respective proteins based on protein sequences obtained 
from the Uniprot database using EditSeq v10.1.2 (DNASTAR Lasergene). Data presentation was carried out using 
Prism v6.
Data collected for peptides of P. falciparum origin was filtered using Excel v14.4.1 to exclude medium confi-
dence peptides (1% ≤ FDR ≤ 5%) and retain only high confidence peptides (FDR ≤ 1%).
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